FDA Drug Application (203053) for EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE by HETERO LABS LTD V

Back to FDA Applications sponsored by HETERO LABS LTD V

Application Number203053
Product Number001
FormTABLET; ORAL
Dosage600MG; 200MG; 300MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameEFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Active IngredientEFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE



Back to FDA Applications sponsored by HETERO LABS LTD V

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.